Methanex (MX) EPS Estimated At $1.58; Juno Lighting (JUNO)’s Sentiment Is 1.04

July 17, 2017 - By Vivian Currie

Analysts expect Methanex Corporation (TSE:MX) to report $1.58 EPS on July, 26 after the close.They anticipate $1.92 EPS change or 564.71% from last quarter’s $-0.34 EPS. T_MX’s profit would be $136.00 million giving it 8.95 P/E if the $1.58 EPS is correct. After having $2.06 EPS previously, Methanex Corporation’s analysts see -23.30% EPS growth. The stock increased 0.09% or $0.05 on July 14, reaching $56.58. About shares traded. Methanex Corporation (TSE:MX) has 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Juno Therapeutics, Inc. is a biopharmaceutical company, which is focused on developing cellular immunotherapies for the treatment of cancer. The company has market cap of $2.81 billion. The Firm is developing cell cancer immunotherapies based on its chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to genetically engineer T cells to recognize and kill cancer cells. It currently has negative earnings. The Company’s product candidates JCAR017, JCAR014, and JCAR015, as well as an additional early stage product candidate incorporating a fully human binding domain, leverage CAR technology to target CD19, a protein expressed on the surface of almost all B cell leukemias and lymphomas.

Among 5 analysts covering Methanex Corporation (TSE:MX), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Methanex Corporation had 27 analyst reports since January 22, 2016 according to SRatingsIntel. As per Friday, January 22, the company rating was maintained by RBC Capital Markets. The stock of Methanex Corporation (TSE:MX) has “Sector Perform” rating given on Friday, January 20 by RBC Capital Markets. Scotia Capital maintained Methanex Corporation (TSE:MX) on Tuesday, January 17 with “Sector Perform” rating. The rating was downgraded by Raymond James on Wednesday, January 4 to “Market Perform”. The rating was maintained by Scotia Capital on Tuesday, December 20 with “Sector Perform”. The stock of Methanex Corporation (TSE:MX) earned “Outperform” rating by Scotia Capital on Tuesday, August 30. As per Wednesday, March 8, the company rating was maintained by Scotia Capital. The stock of Methanex Corporation (TSE:MX) has “Sector Perform” rating given on Tuesday, January 24 by Scotia Capital. Scotia Capital downgraded it to “Sector Perform” rating and $47 target in Friday, December 2 report. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, January 4.

Methanex Corp is a Canada-based producer and supplier of methanol to a range of international markets. The company has market cap of $4.87 billion. The Firm operates production sites in Canada, Chile, Egypt, New Zealand, the United States, as well as Trinidad and Tobago. It has a 28.24 P/E ratio. The Company’s global activities are supported by a global supply chain of terminals, storage facilities and a fleet of methanol ocean tankers.

The stock decreased 2.85% or $0.8 on July 14, reaching $27.26. About shares traded. Juno Therapeutics Inc (JUNO) has declined 39.85% since July 17, 2016 and is downtrending. It has underperformed by 56.55% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.